Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Foy A et.al. 1988 Australia | 203 patients admitted to any speciality, aged between 20 and 75 who were identified at risk of alcohol withdrawal within the first 24 hours. Risk was defined as 1. Intake of 100g or more of alcohol every day for 10 years. 2. Previously documented treatment for alcohol withdrawal 3. Documented current alcohol related problems. Excluded if had fit within the first 24 hours. | Comparative study. | Occurrence of severe alcohol withdrawal symptoms (AWS) | 110 patients scored above 15. 75 received diazepam of which 11 developed severe AWS. 35 were not treated of which 21 developed AWS. | No comparison to a control group assessed without the CIWA-Ar score. |
Relative risk of developing severe AWS depending on CIWA score. | <15=1.92, 16-20=2.74, 21-25=5.46, >25=7.50. | ||||
Sullivan JT. et.al. 1991 USA | 133 patients assessed with CIWA score, 117 treated without a score over a 2 year period, all with a primary diagnosis of alcohol dependence. | Retrospective cohort study. | Drug requirements: CIWA scored vs. non CIWA scored. | Median dose: CIWA 50mg vs. non-CIWA75mg. | Non-blinded. No randomisation, group allocation at doctor's digression. No size estimates performed. |
Length of hospital stay (days) | CIWA 33.9+/-2.2 vs. non- CIWA 4.3+/-2.4 | ||||
Complication rates. | No. of seizures: CIWA;1 vs. non-CIWA;0 | ||||
Reoux JP et.al. 2000 USA | 40 patients admitted over an 8 month period based on ICD-9 code. Exclusion criteria- severe liver disease, primary diagnosis other than alcohol withdrawal, opiate dependent. Patients medicated either depending on the CIWA score, clinical judgement (PRN) or standard set treatment. | Retrospective cohort study. | No. of doses of medication recieved CIWA vs non-CIWA | 1.7+/- 3.1 vs. 10.4+/- 7.9 | Small sample size. No blinding. Male dominance. |
No. of doses of medication recieved CIWA vs. PRN | 1.7+/- 3.1 vs. 4.8+/- 8.6 | ||||
mg of medication received CIWA vs non-CIWA | 82.7+/-153.6 vs. 367.5+/- 98.2 | ||||
mg of medication received CIWA vs. PRN | 82.7+/- 153.6 vs. 204.2+/- 382.9 | ||||
Duration of medication use (hours)CIWA vs non-CIWA | 10.7+/- 20.7 vs. 64.3+/- 60.4 | ||||
Duration of medication use (hours)CIWA vs. PRN | 10.7+/- 20.7 vs. 40.2+/-75.4 | ||||
Adverse events. | Non in either group. | ||||
Hecksel KA 2008 USA | 124 randomly selected patients over a 12 month period who were receiving symptom triggered therapy based on the CIWA-Ar screening tool for alcohol withdrawal. | Randomized prospective cohort study. | To determine whether patients were placed appropriately on STT according to inclusion criteria of being able to communicate verbally and recent alcohol use. | 60 (48%) met both inclusion criteria. | |
9 (8%) could not communicate verbally. | |||||
35 (28%) had not been drinking. | |||||
20 (16%) did not meet either criteria. |